Key facts
- This page summarizes Mitchell E. Levinson's Form 4 filing for Pulse Biosciences, Inc. (PLSE).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 21 May 2021, 17:06.
Mitchell E. Levinson - 20 May 2021 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)
- Reporting relationship
- Director
- Issuer ticker
- PLSE
- Reported as of
- 20 May 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 May 2021, 17:06:37 UTC
- Next SEC filing
- 20 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sandra Gardiner, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mitchell E. Levinson filed Form 4 for Pulse Biosciences, Inc. (PLSE) on 21 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PLSE
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +20,000
- Change %
- Price
- $0.000000
- Shares after
- 20,000
- Date
- 20 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $18.69
- Footnotes
- F1
PLSE
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +45,987
- Change %
- Price
- $0.000000
- Shares after
- 45,987
- Date
- 20 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 45,987
- Exercise price
- $18.69
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date.
Footnote F2
The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date.